Adlai Nortye Biopharma is a global clinical-stage biopharmaceutical company focused on innovative oncology drugs, with our R&D and global clinical operation centers in both China and the United States. With a strategic emphasis on oncology, they have built a global pipeline through collaborations and internal discovery with more than 10 drug candidates in development. They have assembled a world-class management team, built a unique immuno-oncology platforms and partnered with multiple top pharmaceutical companies to promote innovation.

Biotechnology

Adlai Nortye Biopharma

Adlai Nortye Biopharma's headquarters in Hangzhou, China

Paul Jiang

Yixiong Zhang

Xuyang Song, PhD, MBA

Wei HE

Justin Lucas

Peter Chen

Yiheng Grace Hu

Jiaqi Yang, PhD

SzeYu Tong

Shangda Guo

Ian Oldham

Robert Atkinson

Description

People (4)

Wei HE

Peter Chen

Zhaofeng (Zach) Cai

Audrey Xue

Jobs